ArticleOncoTargets and therapy2014

Characterization of a fusion protein of RGD4C and the β-lactamase variant for antibody-directed enzyme prodrug therapy.

Xiaoliang Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.